Possible roles of long-chain sphingomyelines and sphingomyelin synthase 2 in mouse macrophage inflammatory response
- 1 January 2017
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 482 (2) , 202-207
Abstract
No abstract availableKeywords
Funding Information
- Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program
- Ministry of Education, Culture, Sports, Science and Technology, Japan
This publication has 29 references indexed in Scilit:
- Myeloid cell–specific serine palmitoyltransferase subunit 2 haploinsufficiency reduces murine atherosclerosisJournal of Clinical Investigation, 2013
- Sphingolipids as New Biomarkers for Assessment of Delayed-Type Hypersensitivity and Response to TriptolidePLOS ONE, 2012
- Exogenous Ceramide-1-phosphate Reduces Lipopolysaccharide (LPS)-mediated Cytokine ExpressionJournal of Biological Chemistry, 2011
- Reducing Plasma Membrane Sphingomyelin Increases Insulin SensitivityMolecular and Cellular Biology, 2011
- Dynamic Modification of Sphingomyelin in Lipid Microdomains Controls Development of Obesity, Fatty Liver, and Type 2 DiabetesJournal of Biological Chemistry, 2011
- Sphingomyelin synthase 2 (SMS2) deficiency attenuates LPS-induced lung injuryAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2011
- Blood sphingolipidomics in healthy humans: impact of sample collection methodologyJournal of Lipid Research, 2010
- Sphingolipids in inflammation: pathological implications and potential therapeutic targetsBritish Journal of Pharmacology, 2009
- Macrophage Sphingomyelin Synthase 2 Deficiency Decreases Atherosclerosis in MiceCirculation Research, 2009
- Sphingomyelin Synthase 2 Is One of the Determinants for Plasma and Liver Sphingomyelin Levels in MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2009